Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $173K 871 sh | Jan 6, 2026 |
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $106K 534 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $71K 352 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 11 | Dutt SubirChief Sales Officer | Open-market sale · 10b5-1 plan | SELL | $8,722 137 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 11 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $58K 287 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 11 | Dutt SubirChief Sales Officer | Open-market sale · 10b5-1 plan | SELL | $18K 262 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 11 | Mazzara PhilipGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $36K 200 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 11 | Dutt SubirChief Sales Officer | Open-market sale · 10b5-1 plan | SELL | $8,485 131 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 10 | Malcolm JanDirector | Open-market sale · 10b5-1 plan | SELL | $25K 50 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $36K 177 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $18K 86 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $33K 161 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 8 | Graham-Cumming JohnDirector | Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Jan 6, 2026 traded Jan 5, 2026 |
| 7 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $295K 1,292 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 7 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $381K 1,659 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 6 | Sieffert Kristen NPresident | Open-market sale · 10b5-1 plan | SELL | $18K 750 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $3,918 21 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $8,850 46 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $19K 102 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $39K 207 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 0 | Kozarich John WDirector | Open-market sale · 10b5-1 plan | SELL | $17K 91 sh | Jan 6, 2026 traded Jan 2, 2026 |
| 60 | Raghunathan VivekSVP, Engineering and Support | Open-market sale | SELL | $2.60M 11.8K sh | Jan 5, 2026 traded Dec 31, 2025 |
| 53 | Beri SanjayDirector, CEO and Chairman | Open-market sale | SELL | $1.92M 108.6K sh | Jan 5, 2026 traded Dec 31, 2025 |
| 43 | Beri SanjayDirector, CEO and Chairman | Open-market sale | SELL | $5.85M 346.1K sh | Jan 5, 2026 traded Jan 2, 2026 |
| 43 | Beri SanjayDirector, CEO and Chairman | Open-market sale | SELL | $3.05M 175.7K sh | Jan 5, 2026 traded Jan 5, 2026 |
| 31 | Renninger RobertChief Financial Officer | Open-market sale | SELL | $2,043 297 sh | Jan 5, 2026 traded Jan 2, 2026 |
| 25 | Kerdman AlinaSVP, Controller & CAO | Open-market sale · 10b5-1 plan | SELL | $17K 203 sh | Jan 5, 2026 traded Dec 31, 2025 |
| 24 | Perros EvangelosChief Financial Officer | Open-market sale | SELL | $224K 9,750 sh | Jan 5, 2026 traded Jan 5, 2026 |
| 21 | Truong KristinaChief Accounting Officer | Open-market sale | SELL | $17K 2,296 sh | Jan 5, 2026 traded Jan 1, 2026 |
| 21 | Uczekaj JohnDirector, President and COO | Open-market sale | SELL | $1,725 183 sh | Jan 5, 2026 traded Jan 5, 2026 |
| 20 | Feider StephenChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $591K 20.0K sh | Jan 5, 2026 traded Jan 2, 2026 |
| 13 | Mensinger MikeChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $213K 7,200 sh | Jan 5, 2026 traded Jan 2, 2026 |
| 6 | Mensinger MikeChief Product Officer | Open-market sale · 10b5-1 plan | SELL | $18K 600 sh | Jan 5, 2026 traded Jan 2, 2026 |
| 48 | Allison EricChief Product Officer | Open-market sale | SELL | $430K 32.4K sh | Jan 2, 2026 traded Dec 30, 2025 |
| 45 | Liu SuyingDirector, CEO and CFO, 10% Owner | Open-market sale | SELL | $1.00M 200.0K sh | Jan 2, 2026 traded Dec 30, 2025 |
| 45 | Mountain Crest Global Holdings LLC10% Owner | Open-market sale | SELL | $1.00M 200.0K sh | Jan 2, 2026 traded Dec 30, 2025 |
| 40 | Dobek MariaVice President, Accounting | Open-market sale | SELL | $20K 1,462 sh | Jan 2, 2026 traded Jan 2, 2026 |
| 40 | Dhaliwal Harpreet S.Chief Technical Ops Officer | Open-market sale | SELL | $455K 9,743 sh | Jan 2, 2026 traded Dec 31, 2025 |
| 40 | McIver ZachariahChief Medical Officer | Open-market sale | SELL | $37K 2,714 sh | Jan 2, 2026 traded Jan 2, 2026 |
| 39 | Campbell David AlanDirector, President and CEO | Open-market sale | SELL | $111K 8,072 sh | Jan 2, 2026 traded Jan 2, 2026 |